Brief: Bioventus Q4 Adjusted EPS USD 0.07
12/03/2024 11:30
Mar 12 (Reuters) - Bioventus Q4 adjusted EBITDA USD 22 million. * Q4 sales USD 135.4 million
Recent news on Bioventus
See all newsBioventus Inc. reports results for the quarter ended June 30 - Earnings Summary
Bioventus Q2 revenue misses estimates on surgical solutions decline
Bioventus Inc expected to post earnings of 22 cents a share - Earnings Preview
Bioventus Q1 revenue rises 7%, beats expectations
U.S. STOCKS ON THE MOVE -Erasca Inc, Regenxbio, Natgas stocks